About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
GWPH - GW Pharmaceuticals P...| Previous Close | $214.17 | Open | $214.72 |
| Volume | 2.06M | Market Cap | 6.621B |
| Yield | Last Dividend |
| Driven By Stem Is A DaaS Platform Design... | 03/05/21 |
| Driven By Stem was a sponsor at the Benzinga Cannabis Capital Conference on February 25-26, 2021. The information contained in this article in no way ... | |
| Investors: The Marijuana Boom Is Now | I... | 03/03/21 |
| Stocks Analysis by Zacks Investment Research covering: Jazz Pharmaceuticals PLC, GW Pharmaceuticals PLC, Artelo Biosciences Inc. Read Zacks Investment... | |
| Item 9 Labs and Why Franchising is the G... | 02/26/21 |
| Item 9 Labs Corp. is a sponsor and will speak at the Benzinga Cannabis Capital Conference set to take place on February 25-26, 2021. The information c... | |
| The GW Pharma and Parallel Transactions:... | 02/25/21 |
| This month, two groundbreaking deals in cannabis were announced ??? the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals and the combination ... | |
| "Build It And They Will Come" - North St... | 02/24/21 |
| The United States is falling behind the global stage in cannabis research. The United Kingdom, the European Union, Canada and Israel are well in advan... | |
| Cannabis Industry Set For More Consolida... | 02/22/21 |
| Don't miss the opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga's Virtual Cannabis Capital Conference... | |
| Cannabinoids in Focus after GW Pharmaceu... | 02/18/21 |
| This month???s ???6B acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been hailed as a major validation of the medical... | |
| SHAREHOLDER ALERT: WeissLaw LLP Reminds ... | 02/17/21 |
| NEW YORK, Feb. 17, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have an... | |
| Earnings Roundup: Neptune, Item9, GW Pha... | 02/16/21 |
| Neptune Revenue Declines 63% YoY, Shifts To CPG And Branded Products Global health and wellness company Neptune Wellness Solutions Inc. (NASDAQ: NEPT ... | |
| GW Pharmaceuticals: Q4 Earnings Insights | 02/16/21 |
| Shares of GW Pharmaceuticals (NASDAQ:GWPH) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share... | |
| GW Deal With Jazz Spurs Pot Stock Wave, ... | 02/11/21 |
| It???s been a wild ride for GW Pharmaceuticals (NASDAQ:GWPH). Founded in 1998, it took 20 years for the cannabis-centered pharma firm to achieve its f... | |
| SHAREHOLDER ALERT: WeissLaw LLP Reminds ... | 02/10/21 |
| NEW YORK, Feb. 10, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have an... | |
| Cannabis Countdown: Top 10 Marijuana And... | 02/08/21 |
| Welcome to the Cannabis Countdown , the Legal Marijuana Industry???s Number One Curated Weekly News Recap. In This Week???s Edition, We Recap and Coun... | |
| The Week In Cannabis: Stocks Up By Doubl... | 02/05/21 |
| Cannabis stocks had one of their strongest weeks in history. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) acquired GW Pharmaceuticals PLC- ADR (NASDAQ: GW... | |
| Will GW???s multibillion-dollar sale ???... | 02/05/21 |
| Jazz Pharmaceuticals??? planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma a... | |
| GW PHARMACEUTICALS INVESTOR ALERT by the... | 02/04/21 |
| NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (???KSF???) a... | |
| The professionalization of Cannabis Cult... | 02/04/21 |
| Cannabis is a dioecious plant, meaning it can be categorically divided into male and female plants. Male plants produce the pollen necessary for a fem... | |
| British tycoon dubbed 'Dr Pot' sells can... | 02/04/21 |
| Geoffrey Guy got the nickname after his drugs company GW Pharmaceuticals started using cannabis to develop medicines in the US - which has been snappe... | |
| Dr Pot pots ??66m: Cannabis medicine pio... | 02/03/21 |
| Dr Geoffrey Guy has sold GW Pharmaceuticals, the cannabis company he founded in 1998, for ??5.3bn. The company makes Sativex, the first cannabis-based... | |
| SHAREHOLDER ALERT: WeissLaw LLP Investig... | 02/03/21 |
| NEW YORK, Feb. 3, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of d... | |
| ???Dr Pot???s??? ??65m payday as cannabi... | 02/03/21 |
| GW Pharmaceuticals, the Cambridge-based medicinal cannabis pioneer behind epilepsy treatment Epidolex, has been snapped up by rival healthcare group J... | |
| Jazz Pharma to buy GW Pharmaceuticals in... | 02/03/21 |
| GW Pharma's Epidiolex, the first marijuana-derived drug to be approved in the United States, generated sales of over $500 million for the U.K.-based c... | |
| Why GW Pharma's Stock Is Trading Higher ... | 02/03/21 |
| GW Pharmaceuticals PLC (NASDAQ: GWPH ) shares are trading higher Wednesday after the company announced it will be acquired by Jazz Pharmaceuticals (NA... | |
| Jazz Pharma to buy GW Pharma for US$7.2 ... | 02/03/21 |
| Jazz Pharmaceuticals said on Wednesday it had agreed to buy GW Pharmaceuticals in a US$7.2 billion cash-and-stock deal which will bolster its neurosci... | |
| Aphria, Cannabis Stocks Soar as Jazz Pha... | 02/03/21 |
| Marijuana stocks jumped after Jazz Pharmaceuticals agreed to buy cannabinoid-therapeutics company GW. | |
| Kohl's, Sony, Overstock: 5 Top Stock Gai... | 02/03/21 |
| GW Pharmaceuticals, Kohl's, Sony, Nomura Holdings and Overstock.com. | |
| GWPH Merger Investigation: Halper Sadeh ... | 02/03/21 |
| NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether GW Pharmaceuticals plc (NASDAQ: GWPH) and its... | |
| Jazz Pharma to buy GW Pharma for US$7.2 ... | 02/03/21 |
| Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a US$7.2 billion cash-and-stock deal which will bolster its ... | |
| Tilray stock extends rally as Democrat l... | 02/03/21 |
| Summary List Placement Shares of Tilray climbed as much as 22% Wednesday, extending the stock's rally to the second day on the back of encouraging dev... | |
| Jazz Pharmaceuticals to Buy Cannabis-Bas... | 02/03/21 |
| The deal, combining two neuroscience drugmakers, marks a bet by Jazz on the long-term prospects for cannabis-based therapies. | |
| Buy rating | 02/04/21 |
| SVB Leerink downgrades from Outperform to Market Perform rating and raises Price Target from $200.00 to $220.00 | |
| Hold rating | 02/04/21 |
| HC Wainwright & Co. downgrades from Buy to Neutral rating and raises Price Target from $162.00 to $220.00 | |
| Hold rating | 02/04/21 |
| Morgan Stanley downgrades from Overweight to Equal-Weight rating and raises Price Target from $193.00 to $220.00 | |
| Date | 2021-02-16 (AMC) | Est. (EPS/Rev.) | ($0.60)/ 143.07M |
| Actual (EPS/Rev.) | $-0.08/ $148.22 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| High Growth Stocks- Long only | Srini Donapati | 70.00 % | Follow |
| Biotech picks | mr jackson | 50.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
